Ghiringhelli F - Search Results

1

UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice.

Etienne-Grimaldi MC, Boyer JC, Thomas F, Quaranta S, Picard N, Loriot MA, Narjoz C, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C; Collective work by Groupe de Pharmacologie Clinique Oncologique (GPCO-Unicancer); French Réseau National de Pharmacogénétique Hospitalière (RNPGx). Etienne-Grimaldi MC, et al. Among authors: ghiringhelli f. Fundam Clin Pharmacol. 2015 Jun;29(3):219-37. doi: 10.1111/fcp.12117. Epub 2015 May 4. Fundam Clin Pharmacol. 2015. PMID: 25817555

2

[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan].

Boyer JC, Etienne-Grimaldi MC, Thomas F, Quaranta S, Picard N, Loriot MA, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C. Boyer JC, et al. Among authors: ghiringhelli f. Bull Cancer. 2014 Jun;101(6):533-53. doi: 10.1684/bdc.2014.1933. Bull Cancer. 2014. PMID: 24977443 Review. French.

3

Detection of relevant pharmacogenetic information through exome sequencing in oncology.

Verdez S, Albuisson J, Duffourd Y, Boidot R, Reda M, Thauvin-Robinet C, Fumet JD, Ladoire S, Nambot S, Callier P, Faivre L, Ghiringhelli F, Picard N. Verdez S, et al. Among authors: ghiringhelli f. Pharmacogenomics. 2022 Sep;23(14):759-770. doi: 10.2217/pgs-2022-0085. Epub 2022 Aug 31. Pharmacogenomics. 2022. PMID: 36043386

4

Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot study.

Ghiringhelli F, Guiu B, Chauffert B, Ladoire S. Ghiringhelli F, et al. World J Gastroenterol. 2009 Sep 14;15(34):4278-83. doi: 10.3748/wjg.15.4278. World J Gastroenterol. 2009. PMID: 19750570 Free PMC article.

5

Influcence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study.

Lorgis V, Chauffert B, Gentil J, Ghiringhelli F. Lorgis V, et al. Among authors: ghiringhelli f. Anticancer Res. 2012 Sep;32(9):4125-30. Anticancer Res. 2012. PMID: 22993372

6

Improvement in survival of metastatic colorectal cancer: are the benefits of clinical trials reproduced in population-based studies?

Mitry E, Rollot F, Jooste V, Guiu B, Lepage C, Ghiringhelli F, Faivre J, Bouvier AM. Mitry E, et al. Among authors: ghiringhelli f. Eur J Cancer. 2013 Sep;49(13):2919-25. doi: 10.1016/j.ejca.2013.04.001. Epub 2013 Apr 30. Eur J Cancer. 2013. PMID: 23642328

7

5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer.

Morawska K, Goirand F, Marceau L, Devaux M, Cueff A, Bertaut A, Vincent J, Bengrine-Lefevre L, Ghiringhelli F, Schmitt A. Morawska K, et al. Among authors: ghiringhelli f. Oncotarget. 2018 Jan 30;9(14):11559-11571. doi: 10.18632/oncotarget.24338. eCollection 2018 Feb 20. Oncotarget. 2018. PMID: 29545919 Free PMC article.

8

Impact of granulocyte colony-stimulating factor on FOLFIRINOX-induced neutropenia prevention: A population pharmacokinetic/pharmacodynamic approach.

Macaire P, Paris J, Vincent J, Ghiringhelli F, Bengrine-Lefevre L, Schmitt A. Macaire P, et al. Among authors: ghiringhelli f. Br J Clin Pharmacol. 2020 Dec;86(12):2473-2485. doi: 10.1111/bcp.14356. Epub 2020 Jun 5. Br J Clin Pharmacol. 2020. PMID: 32386071 Free PMC article.

9

Raltitrexed and oxaliplatin hepatic arterial infusion for advanced colorectal cancer: a retrospective study.

Khouri C, Guiu B, Cercueil JP, Chauffert B, Ladoire S, Ghiringhelli F. Khouri C, et al. Among authors: ghiringhelli f. Anticancer Drugs. 2010 Jul;21(6):656-61. doi: 10.1097/CAD.0b013e328337d469. Anticancer Drugs. 2010. PMID: 20216061

10

Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapies.

Ghiringhelli F, Vincent J, Guiu B, Chauffert B, Ladoire S. Ghiringhelli F, et al. Invest New Drugs. 2012 Apr;30(2):758-64. doi: 10.1007/s10637-010-9575-3. Epub 2010 Nov 6. Invest New Drugs. 2012. PMID: 21057973 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page